11th Annual World Drug Manufacturing Summit - Pharmaceutical Technology

Latest Issue

Latest Issue
PharmTech Europe

11th Annual World Drug Manufacturing Summit

11th Annual World Drug Manufacturing Summit
26-28th November 2012
Venue: Swissôtel, Düsseldorf, Germany

The Annual World Drug Manufacturing Summit sources and presents leading global case studies from Pfizer, GSK, AstraZeneca, Baxter, Bayer and many more.

The Summit is packed full of real life pharma manufacturing case studies, allowing you to benchmark your business against ‘best in class’ and ensure that you have the tools you need to form a coherent and logical strategy.

Key issues include:

  • Lean deployment, Maintenance and Development
  • QbD Implementation
  • Quality Control & Management
  • Cost Reduction
  • Engineering principles, Facility Upgrade & Maintenance
  • Tech transfer & Scale-up
  • Control & Decision-making Software & Technology
  • Anti-counterfeiting & Serialization

If you have any questions about the new programme, would like to register your interest in speaking at WDM 2012, or would like to book your place please contact Richard Jones on +44 (0)20 7202 7690 or at Richard.jones@wtgevents.com. Please visit www.wdmsummit.com or to book now for the discounted price of £1,495 (usual price £1995 - £500 saving) visit www.wdmsummit.com/summer.


blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
| Weekly

FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
View Results
Eric Langerr Outsourcing Outlook Eric LangerTargeting Different Off-Shore Destinations
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAsymmetric Synthesis Continues to Advance
Jill Wechsler Regulatory Watch Jill Wechsler Data Integrity Key to GMP Compliance
Sean Milmo European Regulatory WatchSean MilmoExtending the Scope of Pharmacovigilance Comes at a Price
From Generics to Supergenerics
CMOs and the Track-and-Trace Race: Are You Engaged Yet?
Ebola Outbreak Raises Ethical Issues
Better Comms Means a Fitter Future for Pharma, Part 2: Realizing the Benefits of Unified Communications
Better Comms Means a Fitter Future for Pharma, Part 1: Challenges and Changes

Click here